Primary Country (Mandatory)

Other Country (Optional)

Set News Language for United States

Primary Language (Mandatory)
Other Language[s] (Optional)
No other language available

Set News Language for World

Primary Language (Mandatory)
Other Language(s) (Optional)

Set News Source for United States

Primary Source (Mandatory)
Other Source[s] (Optional)

Set News Source for World

Primary Source (Mandatory)
Other Source(s) (Optional)
  • Countries
    • India
    • United States
    • Qatar
    • Germany
    • China
    • Canada
    • World
  • Categories
    • National
    • International
    • Business
    • Entertainment
    • Sports
    • Special
    • All Categories
  • Available Languages for United States
    • English
  • All Languages
    • English
    • Hindi
    • Arabic
    • German
    • Chinese
    • French
  • Sources
    • India
      • AajTak
      • NDTV India
      • The Hindu
      • India Today
      • Zee News
      • NDTV
      • BBC
      • The Wire
      • News18
      • News 24
      • The Quint
      • ABP News
      • Zee News
      • News 24
    • United States
      • CNN
      • Fox News
      • Al Jazeera
      • CBSN
      • NY Post
      • Voice of America
      • The New York Times
      • HuffPost
      • ABC News
      • Newsy
    • Qatar
      • Al Jazeera
      • Al Arab
      • The Peninsula
      • Gulf Times
      • Al Sharq
      • Qatar Tribune
      • Al Raya
      • Lusail
    • Germany
      • DW
      • ZDF
      • ProSieben
      • RTL
      • n-tv
      • Die Welt
      • Süddeutsche Zeitung
      • Frankfurter Rundschau
    • China
      • China Daily
      • BBC
      • The New York Times
      • Voice of America
      • Beijing Daily
      • The Epoch Times
      • Ta Kung Pao
      • Xinmin Evening News
    • Canada
      • CBC
      • Radio-Canada
      • CTV
      • TVA Nouvelles
      • Le Journal de Montréal
      • Global News
      • BNN Bloomberg
      • Métro
Proposed class action lawsuit filed against Canadian maker of popular weight loss drug Ozempic

Proposed class action lawsuit filed against Canadian maker of popular weight loss drug Ozempic

CTV
Friday, November 03, 2023 04:52:25 AM UTC

A proposed class action lawsuit has been filed in B.C. Supreme Court alleging the Canadian manufacturer of Ozempic didn’t warn prospective patients about possible complications.

A proposed class action lawsuit has been filed in B.C. Supreme Court alleging the Canadian manufacturer of Ozempic didn’t warn prospective patients about possible complications.

The drug has exploded in popularity since doctors began prescribing it for weight loss.

But 54-year-old Tracy Nygaard was taking Ozempic for its intended purpose, the treatment of Type 2 diabetes. After her first dose, she knew something was wrong.

“My stomach hurt so much, I had pain and bloating and vomiting,” said Nygaard from her home in Quesnel.

Ozempic was very effective at controlling her blood sugar, so Nygaard’s doctor suggested she keep up with the once-weekly injections. But the side effects persisted.

“One of the reactions that I had, I did go to the ER. I said I can’t handle this anymore,” said Nygaard, who did eventually stop talking Ozempic.

“I feel scared that I have permanent damage now,” Nygaard said. “I wish I had been warned that there were severe side effects before I started taking it, so I could have made an informed decision.”

Read full story on CTV
Share this story on:-
More Related News
© 2008 - 2025 Webjosh  |  News Archive  |  Privacy Policy  |  Contact Us